Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Providing healthcare for the transgender and gender diverse
Case Scenario
Miley (she/her), a 21-year-old assigned male at birth, visits your pharmacy to fill a prescription for estradiol 2 mg tablets. She has transitioned...
Will pharmacists finally be included in the Medicare Benefits Schedule?
On Monday, the Albanese government announced plans for the biggest overhaul to Medicare in its 4-decade history, with the primary care sector currently unable to keep up with demand.
Ready for the end of the CPD year?
The end of the continuing professional development (CPD) reporting period is almost here. After a stressful 12 months, Australian Pharmacist has some tips to help make the process simple.
Going bush: rewards of rural pharmacy
Pharmacy in rural and remote areas has a lot to offer, from closer relationships with customers to higher pay, but these opportunities are often...
Pharmacists on dealing with medicine shortages
With medicine shortages continuing to be an issue for the foreseeable future, pharmacists share how they are managing patients’ conditions and expectations.
Lung cancer
Lung cancer is the most common cause of cancer-related death in Australia. Pharmacists have a key role in the education of patients on new targeted therapy and in the identification and management of adverse effects of treatment.
